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Abstract
Background: Flaviviruses, which include Dengue (DV) and West Nile (WN), mutate in response
to immune system pressure. Identifying escape mutants, variant progeny that replicate in the
presence of neutralizing antibodies, is a common way to identify functionally important residues of
viral proteins. However, the mutations typically occur at variable positions on the viral surface that
are not essential for viral replication. Methods are needed to determine the true targets of the
neutralizing antibodies.
Results: Stereophysicochemical variability plots (SVPs), 3-D images of protein structures colored
according to variability, as determined by our PCPMer program, were used to visualize residues
conserved in their physical chemical properties (PCPs) near escape mutant positions. The analysis
showed 1) that escape mutations in the flavivirus envelope protein are variable residues by our
criteria and 2) two escape mutants found at the same position in many flaviviruses sit above clusters
of conserved residues from different regions of the linear sequence. Conservation patterns in T-
cell epitopes in the NS3- protease suggest a similar mechanism of immune system evasion.
Conclusion: The SVPs add another dimension to structurally defining the binding sites of
neutralizing antibodies. They provide a useful aid for determining antigenically important regions
and designing vaccines.
Background
Flaviviruses, +-strand RNA viruses that cause diseases such
as yellow fever (YF), Japanese encephalitis (JE), West Nile
(WN), tick-borne encephalitis (TBE) and Dengue fever
(DV), are endemic in many parts of the world. While
some flaviviruses have relatively stable sequences, others
are extremely variable. For example, some have suggested
the term "quasispecies" for DV, as several different virus
sequences could be isolated from the same blood sample
[1,2]. The many asymptomatic human and animal carri-
ers of these viruses represent an enormous reservoir for
the development of new strains[3,4]. Continuous muta-
tion at positions that are non-essential for replication
allows flaviviruses to evade or confuse the immune sys-
tem. This contributes to the development of fatal infec-
tions, such as Dengue hemorrhagic fever (DHF) [5,6]. To
be effective, vaccines must induce efficient T-cell [7,8] and
neutralizing antibody responses to functionally essential
areas of the viral proteins[9].
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Virology Journal 2005, 2:40 http://www.virologyj.com/content/2/1/40Previous efforts to identify residues in flaviviruses that are
essential for function have used escape mutants, viral
progeny that survive in the presence of neutralizing anti-
bodies to the virus [10-16]. However, while escape vari-
ants may have altered phenotypes[10,14], they do not
prevent the replication of the virus, implying that the
mutations are in residues not essential for function[17].
Here, we present a method that can be used to interpret
escape mutations in a different way, by detecting con-
served residues that are "cloaked" by these variable posi-
tions. These invariant residues are more likely to be the
important targets of neutralizing antibodies the escape
mutants, which typically occur at variable positions.
The method depends on our PCPMer program for analyz-
ing variability, according to physicochemical properties of
the amino acids, in sequence alignments. We have shown
that the position specific variability data generated by the
program, when coupled with structural analysis, can be
used to identify areas that are important for function in
families of related proteins [18-22]. Here, as a paradigm
for the use of the method in vaccine design, we applied
this method to the analysis of escape mutants of
flaviviruses.
We used the PCPMer program to define areas conserved in
physical chemical properties (PCP-motifs) of DV proteins
of known structure. We then color coded the structures
according to PCP-variability, and marked the position of
known escape mutants and viral epitopes. The data
divided the protein surface into a variable face, where all
the escape mutants mapped, and a more conserved face.
These areas were consistent with those previously defined
by experimental methods [23-26]. We find that the escape
mutants found in the same position in several different
flaviviruses lie above highly conserved, known functional
areas of the viral proteins, such as the receptor binding
site, and disulfide bonded residues. These cloaked resi-
dues are more likely to be the true target for a neutralizing
antibody.
Results
Defining PCP-motifs of DV proteins with PCPMer
A "PCP-motif" is an area in a group of related proteins
with conserved physical chemical properties (PCPs). We
have shown in previous work that PCP-motifs correspond
to functional areas of proteins and can be used to identify
functional homologues in sequence databases ([27,21]).
The PCP motifs for two DV proteins of known structure,
the Envelope and the serine protease domain of the non-
structural protein NS3 are shown in Tables 1 and 2. For
Table 1: PCP-Motifs identified for the flavivirus Envelope 
proteins, using the sequence of DV-2env to indicate the 
sequence location and representative sequence. PCPMer 
parameters were: Gap cutoff of 2, length cutoff of 5 and the 
relative entropy range between 1 and 2.5 with a step of 0.1.
Motif No. PCP-motifs
1 9 RDFVEGVSG 17*i
2 24 VLEHGSCVTTMAKNKPTLD 42
3 54 ATLRKYCIEA 63
4 74 CPTQGEP 80F
5 98 DRGWGNGCGLFGKGG 112F
6 116 CAMFTC 121
7 133 ENLEYTV 139
8 151 VGNDT 155
9 159 GKEVKITPQSS 169
10 175 LTGYGTVTMEC 185
11 197 VLLQMK 202
12 209 HRQWFLD 215
13 240 FKNPHAKKQDV 250F
14 281 GHLKCRLRMDKLQLKGMSYSMC 302
15 314 ETQHGT 319
16 332 PCKIPF 337
17 349 GRLITVNP 356
18 368 EAEPPFGD 375**
19 391 WFKKGSSIGQ 400
20 416 GDTAWDFGSLGG 427
21 431 SIGKALHQVFGAI 443
22 448 FSGVSW 453
23 459 IGVIITWIGMNSR 471
24 475 LSVSLVLVGVVTLYL 489
*residues 9–12 are at the C-terminal end of the CD8-T-cell epitope 
mapped for yellow fever [46]
**a Y to H mutation in TBE virus just after this motif is attenuating for 
neurovirulence [44]
F Motifs that form the "fusion tip area" of domain II. Mutation of the 
analogous residue in TBE to the bold and underlined H in motif 13 
prevents fusion [32].
i Residues equivalent to those that form a salt bridge in the TBE-
envelope are bold (R9/E368), those in the interface of the trimer of 
the TBE envelope protein are underlined [31].
Table 2: PCP-motifs identified for the flavivirus NS3 proteases, 
using the sequence of DV-2 NS3 to indicate location and 
representative sequence. The catalytic residues (H51, D75, 
S135) are shadowed; residues in the substrate interaction pocket 
[28] are bold, and areas that are part of known T-cell epitopes 
are underlined.
Motif No. PCP-motifs
1 2 GVLWDVPSP 10
2 29 GILGYSQIGAG 39
3 43 EGTFHTMWHVTRGA 56
4 73 KKDLISYGGGW 83*
5 95 VQVLALEPG 103
6 133 GTSGSP 138**
7 148 GLYGNG 153
8 159 GAYVSAIAQ 167
*C-terminal end, cytotoxic T-cell epitope AA 71–79 [40].
**N-terminal end of 11 mer T-cell activating peptide [5].Page 2 of 10
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Virology Journal 2005, 2:40 http://www.virologyj.com/content/2/1/40convenience in this paper, the motifs are given as areas of
the Dengue virus protein sequence, rather than as the
matrix of numbers relating to the conserved properties at
each position that is their actual description (see
methods).
The PCP-motifs include all the known functional areas of
the proteins, according to previous experimental results,
and indicate areas that are most probably responsible for
the activities that are common to all the flaviviruses. For
example, the motifs of the NS3 protease (Table 2) include
all the catalytic amino acids and all but one of the residues
that interact with a peptide substrate analogue in a crystal
structure of the complex[28].
Mapping PCP-motifs of the DV-Env protein defines a 
conserved face and a fusion tip region
Mapping the motifs of Table 1 on the 3D structure, deter-
mined by X-ray crystallography, of the DV-2 envelope pro-
tein (DV residues 281– 674)[29,30](Figure 2a) shows that
they map primarily to one, conserved face of the mole-
cule. Many of these sequences are involved in interdo-
main and trimer interactions of the envelope protein from
TBE[31]. The plot reveals that three of the motifs occur
near one another at the end of Domain II. These are the
previously defined "fusion peptide" and two other loops
that are as much as 140 amino acids away in the linear
sequence of the protein (the three areas are marked by F in
Table 1). This suggests that the whole tip of the protein is
involved in fusion. We note that mutation in one of these
loops in TBE (at the absolutely conserved H shaded in
Table 1) does indeed effect viral fusion[32].
Visualizing clusters of conserved residues from different 
sequence areas with SVPs
Alternatively, the conservation of each amino acid, repre-
sented by the specific entropy, [33,34], as described in
more detail in Figure 1 and Methods, can be mapped onto
a protein's 3-D structure, by coloring each amino acid. The
higher the specific entropy, the more conserved the posi-
tion. These 3-D plots, which we refer to as "stereophysic-
ochemical variability plots" (Figure 2, 3, 4, 5) can be used
to find conserved areas of the protein, distant in the
sequence, that are close together in 3D space.
The SVP can be used to define the amino acid profile of
antibody binding sites, which have been localized by pep-
tide mapping or escape mutants. An SVP for the DV-env
The relative specific entropy (SE) function of PCPMer (Bin Zhou et al., in preparation) defines motifs even in alignments where the sequence conserva ion varies locallyFigu e 1
The relative specific entropy (SE) function of PCPMer (Bin Zhou et al., in preparation) defines motifs even in 
alignments where the sequence conservation varies locally. The top of the figure shows a section of the sequence 
alignment for the NS3 protein. The next section shows the PCPMer output, indicating the motifs in the NS3 protease accord-
ing to the sequence of DV-2 as a function of the specific entropy level (numbers to the left). PCPMer parameters were: Gap 
cutoff of 2, length cutoff of 5, relative entropy range between 1 and 2.5 with a step of 0.2. Note the conserved sequences 
around the active site residues (bold letters) of the protease are followed by variable regions that retain conservation in one of 
the five physical chemical property vectors. The output is colored to reflect the degree of conservation at each position.Page 3 of 10
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Virology Journal 2005, 2:40 http://www.virologyj.com/content/2/1/40structure (Figure 2b–d), with the specific entropy of each
residue shown by color, shows the two faces, one con-
served (where the PCP-motifs map; 2c) and one variable
(2b). This is also in accord with another analysis of con-
servation in this protein, where only the identical residues
in these 14 flaviviruses were plotted[35]. The SVP indi-
cates that most of the residues on the "inner" face of the
envelope protein (Figure 2c) are conserved in at least one
PCP-vector, even if the sequence at these positions varies.
Escape mutants of the DV-Env protein are in variable 
positions near conserved residues
Known escape mutants of DV[10,26] map to the variable
face of the SVP (Figure 2b, 2d) and are generally in highly
variable positions. This is consistent with a previous
sequence analysis of mutants of tick-borne flaviviruses
[36]. Those in the more conserved positions show a lim-
ited range of alteration in the progeny escape virus. For
example, Residue 112, which is at the border of the fusion
Variability analysis of the envelope protein of DV-2 and illustration of how escape mutants mark cloaked conserved residuesFigure 2
Variability analysis of the envelope protein of DV-2 and illustration of how escape mutants mark cloaked con-
served residues. a) PCP-motifs (blue) common to all flavivirus envelope proteins are mapped on the structure of DV-2 Env 
(PDB file 1OAN; the start and end residues are numbered). Note the high conservation of the fusion peptide (arrow) and two 
loop regions adjacent to it from other areas of the molecule. b) Stereochemical variability plot (SVP) of the DV2-Env (PDB file 
1OKE), showing the per residue variation across the Flaviriridiae. Known escape mutants of DV-2 and DV-3 [10, 26] are 
labeled and the residue names are colored according to their variability. The boxed residues are intermediate in the conserva-
tion scale (white). c and d) Surface plots of the SVP shown in figure 2B, showing the conserved (overall blue, c) face, where the 
motifs of conserved areas map. The variable face (d, mostly red), which matches the orientation of the molecule where the 
escape mutants map to.Page 4 of 10
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residue is either an S or G in all the flavivirus sequences,
with one escape mutant described as "S112G"[26].
Lifting the cloak: the hidden essential residues
To illustrate how the method can be used to define the tar-
get of neutralizing antibodies, the areas around two
escape mutants in the Env protein of DV, both in posi-
tions where escape mutations occur in many different fla-
viviruses, were analyzed.
Example 1: Residue 124 in domain 1
Type specific neutralizing antibodies that bind near this
position have been found for four other flaviviruses[26],
suggesting that the area cloaked by this residue constitutes
an area essential for function. Surviving progeny with
mutations at this position either conserve the residues
hydrophobicity (YF-17D: Met125Ile), or convert it to a
hydrophilic residue (DV: I124N, JE: I126T, MVE: A126E,
TBE: A123K).
Zooming in on this region (figure 3a, detail) reveals that
Ile124 lies above the PCP- motif 54–63 in the folded
structure. The side chains of residues around it cloak two
cysteines that are disulfide bonded, Cys60 and Cys121,
and the highly conserved residue Tyr 59 (figure 3b). This
suggests that converting Ile124 and the residues that sur-
round it in the 3D-structure to small hydrophilic residues
should enhance the immunogenicity of the areas below
that must be blocked to obtain neutralization by the
antibodies.
Example 2: Residue 307 in domain 3
Two DV escape mutants positions, 307 and 311, are part
of a variable surface in domain III (figure 4a). A mutation
at position 307 has also been observed in other flavivi-
ruses. For example, a Lys307Glu mutation has been
implicated in attenuating West Nile neurovirulence[13].
Further, this mutation and another that is close to it struc-
turally, at position 330, block the binding of several anti-
bodies that neutralize WN replication[17]. Attenuated
a) Local surface plot of the DV-Env SVP around residue 124 (which is highly variable but has been colored green here for clar-ity), illustrating how the residue forms part of a patch of variable (red) residuesFigure 3
a) Local surface plot of the DV-Env SVP around residue 124 (which is highly variable but has been colored green here for clar-
ity), illustrating how the residue forms part of a patch of variable (red) residues b) Removing part of the surface reveals how 
I124 lies above the highly conserved residues Cys60-121 (disulfide bonded) and Tyr59 that are distant in the sequence of the 
protein.Page 5 of 10
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residues near this position, which is considered to be an
important site for receptor binding[37]. All this indicates
that while residue 307 can vary, some residue near it must
be essential and conserved.
According to our analysis, Residue 307 and the variable
residues near it cloak two highly conserved aromatic resi-
dues, Phe 306 and Tyr 326, that overlap each other (Figure
4b). Similar analysis (not shown) of the NMR structure of
WN-env in this area points to the equivalent residues
being cloaked by two escape mutants (at positions 307
and 330 in WN), which both block neutralization by
three different monoclonal antibodies[17]. We suggest
that these aromatic residues contribute to the epitopes
detected by the antibodies, and that the antibody prevents
wild type virus replication by blocking their conforma-
tional change during receptor binding. In our alignment
of the Flaviviruses (supplementary data), only the 17D
vaccine strain of Yellow fever varies at these positions.
Mutation studies are now underway to determine whether
these residues play a role in attenuation.
T-cell epitopes in NS3 protease: variable residues alter 
binding to peptides containing essential conserved 
positions
A similar pattern can be seen with T-cell epitopes, which
are also important determinants of the immune response
[38,39]. Two dominant T-cell epitopes have been identi-
fied in the NS3 of DV, the protease that cleaves the poly-
protein at several positions, at residues 71–79[40] and
133–143[5]. Both of these epitopes contain amino acids
that are essential for protease activity, D75 and S135
respectively. In the SVP representation of the crystal struc-
ture [41] of the DV-2 NS3 protease domain (Figure 5),
both the conserved essential amino acids are surrounded
by variable residues which will alter binding to T-cell anti-
gens. This could be the basis for reduced binding to the
immune surveillance (HLA alleles) and clearance mecha-
nisms in infected individuals. For the first epitope, the
determinant for cytotoxic T-cell activation by DV-2 or DV-
3 serotype is in one variable amino acid, D71[40], which
is S71 in DV-3 serotypes (Figure 1). This sort of analysis
can aid in choosing vaccine strains, on the basis of how
their sequences conform to the known binding signatures
a) Local surface plot of the area around two escape mutant positions in domain IIIFigure 4
a) Local surface plot of the area around two escape mutant positions in domain III. Residues 307 and 311 are highly 
variable and have been colored green here for visibility. The faint blue area on the surface near residue 307 comes from a 
highly conserved aromatic residue, Phe306, which lies under the variable residue and forms a cluster with another conserved 
residue, Tyr326 (b).Page 6 of 10
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cell culture.
Discussion
While residue conservation has long been recognized as a
way to detect important areas of viral proteins[35,42,43],
the new tools presented here for distinguishing conserva-
tion with respect to the PCPs of the amino acid side chains
provide a rapid way to interpret an ensemble of sequence
and escape mutant data. Plotting per residue conservation
of physical chemical properties in the form of SVPs per-
mits one to rapidly detect which residues are most likely
to contribute to the epitope face (Figure 2b,d), and which
are most important for the function of the virus (Figure
2a,c, Table 1 and 2). As we show, the mathematical meth-
ods are robust to sample size (in this case, PCPmer analy-
sis with 8 or 14 dependable virus sequences gave similar
plots, as described in Methods), and the specific entropy
criterion is a useful measure of the importance of residues.
For example, the PCP-motifs in the NS3 protease domain
contain all amino acids known to be important for func-
tion and substrate binding (Table 2 and Figure 5).
Applying the PCPMer decomposition methods to the fla-
vivirus family aided in interpreting experimental results
and suggested site specific alterations that can be tested for
vaccine design. PCPMer motifs, combined with structural
analysis, are a rapid way to identify functionally impor-
tant areas of proteins[21,22]. Colored SVPs supply a
fourth dimension, variability, to a crystal or model struc-
ture, that is a valuable aid in interpreting experimental
data. Mapping known escape mutants on SVPs shows they
The conserved essential residues in two serotype specific T-cell epitopes of the NS3 protease are followed by variable residues that will affect MHC bindingFigure 5
The conserved essential residues in two serotype specific T-cell epitopes of the NS3 protease are followed by 
variable residues that will affect MHC binding. The crystal structure of the NS3 protease of DV-2 is colored according 
to sequence variability across the flaviviruses(see figure 1 and 2 for details). The catalytic triad sidechains are shown in neon 
and labeled. The T-cell epitopes (right) around the catalytic residues Asp75 (residues 71–79), and Ser135 (133–143), are 
shown as space filling and color coded to reflect variability, except that the 100% conserved catalytic residues are both black.Page 7 of 10
(page number not for citation purposes)
Virology Journal 2005, 2:40 http://www.virologyj.com/content/2/1/40occur in areas of high variability. While the altered
residues in escape mutants may have deleterious effects
under some growth conditions[10,14,36,44], they are
confined to residues that are not essential for replication.
The masked, conserved residues below them are more
likely to be important. For example, the escape mutants at
positions 124 and 307 (Figure 3 and 4) mark the site of
antibody binding, but the SVP suggests that conserved
amino acids, close in space but 20–60 residues away in
the linear sequence, are more important for neutraliza-
tion. Similar principles may also apply to T-cell epitopes,
according to the NS3 example (Figure 5). The SVP can fur-
ther be used to suggest other amino acids in a composite
site could be altered to better direct antibodies to an
essential area of the protein.
An effective immune response must be generated against
the conserved regions of the viral proteins, and not be
diverted by the variable cloak around them. Our analysis
of the whole range of flaviviruses indicates that physico-
chemical properties remain constant even in stretches of
residues that would appear by other measures to be varia-
ble. The SVP methodology provides a novel way to select
mutants or design a virus so as to enhance the accessibility
of the conserved residues that are normally cloaked.
Conclusion
We have shown that PCP motifs and SVPs provide a rapid
method to obtain information from viral sequence data.
Once identified, these areas can be used to design vaccine
candidate recombinant viruses or individual proteins that
will more efficiently stimulate an effective immune
response to these essential areas. We anticipate that the
PCPmer program and related visualization tools will be a
routine method in the future for analyzing sequence data
of variable virus sequences.
Methods
Variability analysis
A large set (237) of physicochemical properties of amino
acid side chains were reduced to five descriptors (E1-E5)
by multidimensional scaling [34]. The 5 descriptors sum-
marize all known quantitative properties that differentiate
the sidechains, including among others the hydrophobic-
ity (defined in numerous ways), amino acid size, ten-
dency to occur in secondary structures, charge, binding to
various affinity chromatography columns. These descrip-
tors offer an alternative to the commonly used scoring
matrices, such as the PAM series and Gonnet, which are
based on statistical analysis of amino acid substitutions,
to determine areas of residue conservation in proteins.
Our program suite, PCPMer http://129.109.59.110/
BinZhou/PCPMer/index.html, defines areas of conserva-
tion in aligned protein sequences according to the values
of the five vectors at each position in a sequence align-
ment [27,34]. The user specified values dictate allowed
gaps, minimum length, and entropy range for the motifs.
To determine the information content of the pattern of
residue properties in a column of the multiple alignment,
MOTIFMAKER determines a "specific entropy"  value
of the component Ei at position k relative to the expected
random distribution [27] :
The term "entropy" is used here as it is in information sci-
ence, as a measure of the uncertainty of a given event [45].
The relative entropy is thus the observed conservation of
the physical chemical property vectors (b = 1–5) of resi-
dues in a column relative to that which would be expected
if the position varied randomly. In this case, a high spe-
cific entropy indicates that the conservation in a column
of a multiple alignment, according to a given physical
property vector, is significantly greater than chance.
Relative specific entropy
Even in variable areas of sequence alignments, there may
be a pattern of conservation in one of the vectors that
underlies the amino acid sequence diversity. A relative
specific entropy scale can be used to determine motifs in
alignments where the variability depends on position in
the sequence. Alternatively, a sliding entropy scale can be
used to define particularly conserved regions in
alignments that are generally more homogeneous in char-
acter. Figure 1 illustrates the usefulness of this feature. The
top rows show a section of the alignment of NS3 proteins
from 8 flaviviruses. The lower section shows the output of
PCPMer for this area, according to which residues in the
top (marker) sequence would be part of a motif at each
specific entropy level. The program automatically takes
the most highly conserved areas in each section of the
alignment to be motifs.
PCP-motif definition
The user can choose the minimum length of motifs
("length cutoff"), the maximum number of variable posi-
tions between two conserved ones ("Gap cutoff") and the
specific entropy range for defining motifs in PCPMer. For
the sake of simplicity in this paper, the motifs in Figure 1
and Tables 1 and 2 are given according to the top
sequence in the alignment from which they were derived.
However, the actual definition of the PCP-motifs is a
series of numerical matrices, that define the type and
degree of conservation of the physical chemical properties
of each column in the original sequence alignment. These
ℜk
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is the observed fraction of the component i in the bin b
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bases, using the MOTIFMINER program, to identify pro-
teins that contain sequences similar to the PCP-motifs
defined for the initial set of proteins [27]. In this work, we
have chosen to identify PCP-motifs as highly conserved
areas of the viral proteins whose conservation would indi-
cate an important functional or structural role.
Stereophysicochemical variability plots
The plots of Figures 2 and 3 were drawn with MOLMOL,
from the PDB coordinate files of the crystal structures,
using a macro that colors each residue position according
to the specific entropy values determined by PCPMer. The
median of a histogram of the number of residues at each
specific entropy level was defined as the midpoint in the
color scheme. The highest specific entropy for any residue
was set to blue and the lowest to red.
Flavivirus alignment
The whole genome sequences of 8 flaviviruses that
included representatives of each DV serotype were down-
loaded from GENBANK and the areas for the envelope
and NS3 protein selected (alignments are provided as sup-
plementary data). The sequences were aligned with CLUS-
TALW using a GONNET matrix and standard set
conditions. This alignment was used for the initial analy-
sis of the envelope protein and the analysis of the NS3
protease shown in Figures 1 and 3. To test the robustness
of the method, a second alignment of 14 flavivirus
sequences (Supplementary data 1; used for Figures 2, 3, 4)
for the envelope protein was generated and the analysis
was repeated. There was little or no difference in the posi-
tional variability or the specific entropy calculations with
the larger number of sequences, but the ends of two of the
motifs were slightly different.
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